XRP price breakout hopes slow as ETF inflows hit their weakest week since launch. Yet a 284% rise in buying keeps the bullish ...
6h
Is Trevi Therapeutics (TRVI) Building a Multi-Indication Moat With Its Nalbuphine ER Cough Strategy?
Trevi Therapeutics recently outlined past and upcoming milestones for its chronic cough portfolio, including an FDA End-of-Phase 2 meeting in early 2026 and planned Phase 3 and Phase 2b trial ...
US Spotify charts show old songs winning. 10 of top 27 positions are catalogue tracks, Fleetwood Mac, Prince claim premium ...
The S&P/ASX 200 is set to open higher after the S&P 500 closed at all-time highs overnight. Here are today's top stories.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback